Identification and validation of potential biomarkers for the detection of dysregulated microrna by QPCR in patients with colorectal adenocarcinoma

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Wu, Xiaobing ^a   Xu, Xuehu ^a   Li, Shuling ^a   Wu, Shangbiao ^a   Chen, Rong ^a   Jiang, Qingping ^a   Liu, Haibo ^a   Sun, Yan ^a   Li, Yong ^a   Xu, Yuandong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 145; MICRORNA 4469; MICRORNA 4510; MICRORNA 99B; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; VERY ELDERLY; ADENOCARCINOMA; COLON; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; RECTUM; VALIDATION STUDY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; COLON; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM; YOUNG ADULT;

EID: 84925625558     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120024     Document Type: Article

References (25)

1. Taherian H, Tafvizi F, Fard ZT, Abdirad A. Lack of association between human papillomavirus infection and colorectal cancer. Prz Gastroenterol. 2014; 9: 280-284. doi: 10.5114/pg.2014.46163 PMID: 25396002
2. Altobelli E, Lattanzi A, Paduano R, Varassi G, di Orio F. Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Prev Med. 2014; 62: 132-141. doi: 10.1016/j.ypmed.2014.02.010 PMID: 24530610
3. Kleist B, Xu L, Kersten C, Seel V, Li G, Poetsch M. Single nucleotide polymorphisms of the adult intestinal stem cell marker Lgr5 in primary and metastatic colorectal cancer. Am J Transl Res. 2012; 4: 279-290. PMID: 22937206
4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30. doi: 10.3322/caac.21166 PMID: 23335087
5. Nassar FJ, El Sabban M, Zgheib NK, Tfayli A, Boulos F, Jabbour M, et al. MiRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study. PLoS One. 2014; 9: e107566. doi: 10.1371/journal.pone.0107566 PMID: 25232827
6. Hu A, Huang JJ, Xu WH, Jin XJ, Li JP, Tang YJ, et al. MiR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival. Am J Transl Res. 2014; 6: 604-613. PMID: 25360224
7. Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H, et al. Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer. Am J Transl Res. 2014; 6: 391-401. PMID: 25075256
8. Kasinski AL, Slack FJ. MicroRNAs en route to the clinic: progress in validating and targeting micro-RNAs for cancer therapy. Nat Rev Cancer. 2011; 11: 849-864. doi: 10.1038/nrc3166 PMID: 22113163
9. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75: 843-854. PMID: 8252621
10. Mayne GC, Hussey DJ, Watson DI. MicroRNAs and esophageal cancer-implications for pathogenesis and therapy. Curr Pharm Des. 2013; 19: 1211-1226. PMID: 23092342
11. Hamfjord J, Stangeland AM, Hughes T, Skrede ML, Tveit KM, Ikdahl T, et al. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One. 2012; 7: e34150. doi: 10.1371/journal.pone.0034150 PMID: 22529906
12. Xu XH, Wu XB, Wu SB, Liu HB, Chen R, Li Y. Identification of miRNAs Differentially Expressed in Clinical Stages of Human Colorectal Carcinoma-An Investigation in Guangzhou, China. PLoS ONE. 2014; 9: e94060. doi: 10.1371/journal.pone.0094060 PMID: 24743265
13. -ΔΔCT Method. Methods. 2001; 25: 402-408. PMID: 11846609
14. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005; 353: 1793-1801. PMID: 16251535
15. Zhu W, Liu X, He J, Chen D, Hunag Y, Zhang YK. Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer. 2011; 11: 393. doi: 10.1186/1471-2407-11-393 PMID: 21920043
16. Mosakhani N, Sarhadi VK, BorzeI, Karjalainen-Lindsberg ML, Sundström J, Ristamäki R, et al. Micro-RNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer. 2012; 51: 1-9. doi: 10.1002/gcc.20925 PMID: 21922590
17. Li M, Gu J. Changing patterns of colorectal cancer in chia over a period of 20 years. Word J Gastroenterol. 2005; 11: 4685-4688.
18. Bao Y, Guo Y, Li Z, Fang W, Yang Y, Li X, et al. MicroRNA profiling in Muc2 knockout mice of colitisassociated cancer model reveals epigenetic alterations during chronic colitis malignant transformation. PLoS One. 2014; 9: e99132. doi: 10.1371/journal.pone.0099132 PMID: 24941171
19. Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, et al. Characterization of global micro-RNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer. 2009; 9: 374. doi: 10.1186/1471-2407-9-374 PMID: 19843336
20. Yuan W, Sui C, Liu Q, Tang W, An H, Ma J. Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer. PLoS One. 2014; 9: e102017. doi: 10.1371/journal.pone. 0102017 PMID: 25019299
21. Furukawa S, Kawasaki Y, Miyamoto M, Hiyoshi M, Kitayama J, Akiyama T. The miR-1-NOTCH3-Asef pathway is important for colorectal tumor cell migration. PLoS One. 2013; 8: e80609. doi: 10.1371/journal.pone.0080609 PMID: 24244701
22. Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C,et al. MiRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res. 2012; 10: 504-515. doi: 10.1158/1541-7786.MCR-11-0342 PMID: 22343615
23. Kunte DP, DelaCruz M, Wali RK, Menon A, Du H, Stypula Y, et al. Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening. PLoS One. 2012; 7: e45591. doi: 10.1371/journal.pone.0045591 PMID: 23049818
24. Li J, Du L, Yang Y, Wang C, Liu H, Wang L, et al. MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett. 2013; 329: 84-90. doi: 10.1016/j.canlet.2012.10.019 PMID: 23111103
25. Sun Y, Shen S, Liu X, Tang H, Wang Z, Yu Z, et al. MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 incolorectal carcinoma. Mol Cell Biochem. 2014; 390: 19-30. doi: 10.1007/s11010-013-1950-x PMID: 24402783